Regional immunotherapy of metastatic renal cell carcinoma |
| |
Authors: | Heinzer H Huland E Huland H |
| |
Affiliation: | Klinik und Poliklinik für Urologie, Universit?tsklinikum Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg. heinzer@uke.uni-hamburg.de |
| |
Abstract: | We summarized the current literature concerning regional immunotherapy of pulmonary metastases in metastatic renal cell carcinoma and other malignancies using inhaled interleukin-2 (IL-2). Inhaled IL-2 therapy is associated with minimal toxicity and is effective in preventing progression in metastatic renal cell carcinoma, melanoma, and possibly other diseases such as breast cancer. Local (physiologic) use and systemic (pharmacologic) use of IL-2 are not mutually exclusive; a combination may be very appropriate in metastatic cancer. Local physiologic therapy intensifies treatment without intensifying toxicity. |
| |
Keywords: | Schlüsselw?rter Nierenzellkarzinom Immuntherapie Interleukin-2 Interferon |
本文献已被 PubMed SpringerLink 等数据库收录! |